What is the present valuation and projected CAGR of the patient risk stratification market?
The patient risk stratification market size has grown exponentially in recent years. It will grow from $2.15 billion in 2024 to $2.82 billion in 2025 at a compound annual growth rate (CAGR) of 31.3%. The growth in the historic period can be attributed to increased adoption of digitization, increased risk, rising geriatric population, rising frequency of medical errors, and rising adoption of electronic health records (EHR).
The patient risk stratification market size is expected to see exponential growth in the next few years. It will grow to $8.30 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to rising middle-class and health insurance, increasing prevalence of chronic diseases, growing adoption of predictive analytics, growing emphasis on social determinants of health (SDOH), and expanding use of technology. Major trends in the forecast period include advancements in analytics, artificial intelligence (AI), machine learning, technological advancements, innovative tools, technological advancements in healthcare, wearable technology, and remote monitoring.
Get Your Free Sample of The Global Patient Risk Stratification Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp
What key drivers have fueled the patient risk stratification market’s development over the years?
The growing burden of chronic diseases is expected to propel the growth of the patient risk stratification market going forward. Chronic diseases are long-lasting health conditions that persist for extended periods, typically three months or longer. The growing burden of chronic diseases can be attributed to an aging population, unhealthy lifestyles, urbanization, environmental factors, limited healthcare access, economic disparities, and increased stress levels. Patient risk stratification helps identify individuals at different risk levels for chronic diseases, allowing for personalized care, early intervention, better resource allocation, and improved health outcomes. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the number of individuals aged 50 and older with at least one chronic illness is projected to increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Furthermore, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, chronic diseases accounted for 74% of all deaths globally, with 41 million deaths annually. Cardiovascular diseases cause 17.9 million deaths, cancer causes 9.3 million, chronic respiratory diseases cause 4.1 million, and diabetes causes 2.0 million deaths. Therefore, the growing burden of chronic diseases drives the patient risk stratification market.
What is the segmentation for the patient risk stratification market?
The patient risk stratification market covered in this report is segmented –
1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: Healthcare Providers, Healthcare Payers, Other End Users
Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report
Who are the most influential companies in the patient risk stratification market?
Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation
How will emerging trends drive the patient risk stratification market throughout the forecast period?
Major companies operating in the patient risk stratification market are focusing on technological advancements in healthcare, such as artificial intelligence (AI) in disease screening, to improve early detection, enhance patient outcomes, and reduce healthcare costs by enabling more accurate risk assessments and personalized treatment plans. AI in disease screening utilizes sophisticated algorithms and machine learning to examine medical data, enabling early disease detection and improving diagnostic accuracy by quickly analyzing large amounts of information. For instance, in May 2024, WELL Health Technologies Corporation, a Canada-based healthcare company, and its investee company HEALWELL AI, a Canada-based healthcare company focused on AI and data science for preventative care, launched WELL AI Decision Support (WAIDS). It is aimed at rare diseases and now includes screening for chronic conditions such as kidney disease, hypertension, and diabetes. It can detect over 100 diseases and provide risk stratification, helping clinicians identify care gaps and access actionable data at the point of care.
What are the major regional insights for the patient risk stratification market, and which region holds the top position?
North America was the largest region in the patient risk stratification market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Patient Risk Stratification Market Report 2025 Offer?
The patient risk stratification market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Patient risk stratification is the process of assessing and categorizing patients based on their risk of experiencing adverse health outcomes. It is used to identify high-risk patients for targeted interventions, optimize resource allocation, facilitate preventive care, improve care coordination, enhance patient outcomes, reduce costs, and support population health management.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20917
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
